• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


8.3000 USD 0.1000 1.19%

As of 20:10:00 ET on 07/25/2014.

Snapshot for Verastem Inc (VSTM)

Open: 8.2700 Day's Range: 8.1300 - 8.4000 Volume: 135,926
Previous Close: 8.4000 52wk Range: 7.1000 - 16.6000 1-Yr Rtn: -43.84%

Stock Chart for VSTM

No chart data available.
  • VSTM:US 8.3000
  • 1D
  • 1M
  • 1Y
Interactive VSTM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VSTM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.8900
Est. EPS (USD) (12/2014) -2.0750
Est. PEG Ratio -
Market Cap (M USD) 214.43
Shares Outstanding (M) 25.83
30 Day Average Volume 232,042
Price/Book (mrq) 1.9443
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VSTM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VSTM

Verastem Inc., is a clinical biopharmaceutical company. The Company focuses on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Verastem also develops proprietary companion diagnostics for stem cells. The Company's technology allows the creation of stable programs for various signaling pathways.

Christoph H WestphalChairman/Co-FounderRobert ForresterPresident/CEO
John B Green "Jack"Chief Financial OfficerDaniel PatersonChief Business Officer
More Company Profile & Key Executives for VSTM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil